Two Sigma Advisers’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,026,567
| Closed | -$6.17M | – | 2856 |
|
2022
Q4 | $6.17M | Buy |
1,026,567
+82,454
| +9% | +$496K | 0.02% | 697 |
|
2022
Q3 | $5.5M | Sell |
944,113
-57,000
| -6% | -$332K | 0.02% | 690 |
|
2022
Q2 | $5.98M | Buy |
1,001,113
+57,700
| +6% | +$344K | 0.02% | 693 |
|
2022
Q1 | $4.41M | Buy |
943,413
+385,300
| +69% | +$1.8M | 0.01% | 848 |
|
2021
Q4 | $1.38M | Sell |
558,113
-523,500
| -48% | -$1.3M | ﹤0.01% | 1378 |
|
2021
Q3 | $3.19M | Sell |
1,081,613
-90,600
| -8% | -$267K | 0.01% | 1004 |
|
2021
Q2 | $2.93M | Buy |
1,172,213
+652,000
| +125% | +$1.63M | 0.01% | 1114 |
|
2021
Q1 | $1.51M | Buy |
520,213
+408,600
| +366% | +$1.19M | ﹤0.01% | 1411 |
|
2020
Q4 | $359K | Sell |
111,613
-110,370
| -50% | -$355K | ﹤0.01% | 1989 |
|
2020
Q3 | $477K | Buy |
221,983
+130,100
| +142% | +$280K | ﹤0.01% | 1846 |
|
2020
Q2 | $107K | Sell |
91,883
-1,000
| -1% | -$1.17K | ﹤0.01% | 2352 |
|
2020
Q1 | $85K | Sell |
92,883
-800
| -0.9% | -$732 | ﹤0.01% | 2319 |
|
2019
Q4 | $148K | Sell |
93,683
-18,900
| -17% | -$29.9K | ﹤0.01% | 2226 |
|
2019
Q3 | $94K | Sell |
112,583
-600
| -0.5% | -$501 | ﹤0.01% | 2116 |
|
2019
Q2 | $97K | Sell |
113,183
-1,300
| -1% | -$1.11K | ﹤0.01% | 2216 |
|
2019
Q1 | $111K | Sell |
114,483
-1,000
| -0.9% | -$970 | ﹤0.01% | 2183 |
|
2018
Q4 | $85K | Buy |
115,483
+14,200
| +14% | +$10.5K | ﹤0.01% | 2235 |
|
2018
Q3 | $219K | Buy |
101,283
+4,400
| +5% | +$9.51K | ﹤0.01% | 2060 |
|
2018
Q2 | $482K | Buy |
+96,883
| New | +$482K | ﹤0.01% | 1937 |
|
2016
Q2 | – | Sell |
-1,120
| Closed | -$6K | – | 2319 |
|
2016
Q1 | $6K | Buy |
+1,120
| New | +$6K | ﹤0.01% | 2017 |
|
2013
Q3 | – | Sell |
-6,223
| Closed | -$65K | – | 2004 |
|
2013
Q2 | $65K | Buy |
+6,223
| New | +$65K | ﹤0.01% | 1531 |
|